P. Segui

656 total citations
12 papers, 471 citations indexed

About

P. Segui is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, P. Segui has authored 12 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in P. Segui's work include Systemic Lupus Erythematosus Research (6 papers), Coenzyme Q10 studies and effects (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). P. Segui is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Coenzyme Q10 studies and effects (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). P. Segui collaborates with scholars based in Spain, United Kingdom and United States. P. Segui's co-authors include C. López-Pedrera, Eduardo Collantes‐Estévez, C. Pérez‐Sánchez, Nuria Barbarroja, M. Á. Aguirre, Patricia Ruiz‐Limón, Antonio Rodríguez‐Ariza, José M. Villalba, José A. González‐Reyes and I. Arias de la Rosa and has published in prestigious journals such as Blood, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

P. Segui

11 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Segui Spain 9 253 234 179 69 58 12 471
Dres Damgaard Denmark 15 217 0.9× 233 1.0× 191 1.1× 91 1.3× 36 0.6× 25 586
Barbara Stypińska Poland 13 187 0.7× 179 0.8× 145 0.8× 92 1.3× 39 0.7× 31 425
M. C. Ábalos‐Aguilera Spain 8 148 0.6× 151 0.6× 106 0.6× 33 0.5× 43 0.7× 19 303
Shunhua Guo United States 12 138 0.5× 179 0.8× 68 0.4× 19 0.3× 31 0.5× 22 371
Benoît Manfroi France 9 125 0.5× 358 1.5× 134 0.7× 33 0.5× 103 1.8× 13 575
Keiichi Iwanami Japan 12 162 0.6× 248 1.1× 85 0.5× 30 0.4× 41 0.7× 25 423
Simon Strietholt Germany 7 130 0.5× 97 0.4× 193 1.1× 63 0.9× 35 0.6× 10 368
In Seol Yoo South Korea 11 95 0.4× 142 0.6× 87 0.5× 28 0.4× 38 0.7× 31 317
Carlos Horacio Muñoz‐Vahos Colombia 10 151 0.6× 111 0.5× 127 0.7× 32 0.5× 24 0.4× 21 286
Wouter Eijgelaar Netherlands 7 52 0.2× 270 1.2× 119 0.7× 46 0.7× 39 0.7× 8 401

Countries citing papers authored by P. Segui

Since Specialization
Citations

This map shows the geographic impact of P. Segui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Segui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Segui more than expected).

Fields of papers citing papers by P. Segui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Segui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Segui. The network helps show where P. Segui may publish in the future.

Co-authorship network of co-authors of P. Segui

This figure shows the co-authorship network connecting the top 25 collaborators of P. Segui. A scholar is included among the top collaborators of P. Segui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Segui. P. Segui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rosa, I. Arias de la, Lourdes Ladehesa-Pineda, M. Ruiz-Ponce, et al.. (2025). Molecular insights into the relationship between sustained CRP elevation and endothelial dysfunction in axial spondyloarthritis. RMD Open. 11(3). e005746–e005746.
2.
Pérez‐Sánchez, C., M. Luque-Tévar, M. C. Ábalos‐Aguilera, et al.. (2021). Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Arteriosclerosis Thrombosis and Vascular Biology. 41(9). 2417–2430. 40 indexed citations
3.
Aguirre, M. Á., M. Luque-Tévar, M. C. Ábalos‐Aguilera, et al.. (2020). Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 865–877. 19 indexed citations
4.
Pérez‐Sánchez, C., I. Arias de la Rosa, M. Á. Aguirre, et al.. (2018). Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. Haematologica. 103(5). 908–918. 31 indexed citations
5.
Pérez‐Sánchez, C., M. Á. Aguirre, Patricia Ruiz‐Limón, et al.. (2017). Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile. Arteriosclerosis Thrombosis and Vascular Biology. 37(10). 1923–1932. 63 indexed citations
6.
Pérez‐Sánchez, C., Patricia Ruiz‐Limón, M. Á. Aguirre, et al.. (2017). Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients. Journal of Autoimmunity. 82. 31–40. 97 indexed citations
7.
Pérez‐Sánchez, C., M. Á. Aguirre, Patricia Ruiz‐Limón, et al.. (2017). AB0127 ANTI-DS-DNA antibodies regulate atherothrombosis in systemic lupus erythematosus through the induction of netosis, inflammation and endothelial activation. Annals of the Rheumatic Diseases. 76. 1091–1091. 1 indexed citations
8.
Pérez‐Sánchez, C., M. Á. Aguirre, Patricia Ruiz‐Limón, et al.. (2016). ‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’. Scientific Reports. 6(1). 31375–31375. 47 indexed citations
9.
López-Pedrera, C., C. Pérez‐Sánchez, M. Á. Aguirre, et al.. (2015). THU0398 Beneficial Effects of in Vivo Ubiquinol Supplementation on Athero-Thrombosis Prevention in Antiphospholipid Syndrome Patients. Preliminary Results of a Clinical Trial. Annals of the Rheumatic Diseases. 74. 340–341. 2 indexed citations
10.
Ruiz‐Limón, Patricia, Nuria Barbarroja, C. Pérez‐Sánchez, et al.. (2014). Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. Annals of the Rheumatic Diseases. 74(7). 1450–1458. 46 indexed citations
11.
Barbarroja, Nuria, C. Pérez‐Sánchez, Patricia Ruiz‐Limón, et al.. (2014). Anticyclic Citrullinated Protein Antibodies Are Implicated in the Development of Cardiovascular Disease in Rheumatoid Arthritis. Arteriosclerosis Thrombosis and Vascular Biology. 34(12). 2706–2716. 47 indexed citations
12.
Pérez‐Sánchez, C., Patricia Ruiz‐Limón, M. Á. Aguirre, et al.. (2012). Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment. Blood. 119(24). 5859–5870. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026